Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DAPA-Shuttle1: Dapagliflozin in Heart Failure
NCT04080518Phase 4Completed
- Sponsor
- National Heart Centre Singapore
- Start
- Nov 2019
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in heart failure (HF), sponsored by National Heart Centre Singapore. Started Nov 2019; status: completed.
02
Drugs
dapagliflozin
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT04080518.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04080518.